CClinicalTrials.gg
CompletedNCT06052189Updated Sep 25, 2023

Ultrasonographic Parameters in Prediction of Difficult Laryngoscopy in Non-suspected Difficult Airway Patients

An observational study in Ultrasound, Difficult Laryngoscopy and Prediction, sponsored by Tanta University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-09-25.

Sponsored by Tanta University · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
85
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study aims to evaluate the ultrasonographic parameters (distance from skin to epiglottis (DSE) and distance from skin to vocal cords (DSVC)) as preoperative predictors of difficult laryngoscopy in non-suspected difficult airway patients undergoing elective surgery.

Read the detailed description

Airway management is an integral part of general anesthesia. It simply aims to secure the patient's airway and achieve adequate ventilation and oxygenation for the patient undergoing surgery under general anesthesia. Unsuccessful airway management due to the unexpected difficulty in laryngoscopy is a life-threatening situation and may lead to morbidity and mortality.

Many conventional clinical tests are used in preoperative airway assessment such as modified Mallampati classification, Thyro-mental distance, inter-incisor distance, cervical mobility, and neck circumference, which are used to predict difficulty in the airway, but they have limited value and low sensitivity and specificity. Difficult laryngoscopy cannot be always predicted based on the preoperative assessment by conventional clinical tests. Some patients are thought to have an easy airway by clinical tests, but they show an unexpected difficulty in the laryngoscopy.

The laryngeal view of the patient can be assessed and graded during direct laryngoscopy using the Cormack and Lehane grading scale and its modification that describes the laryngoscopy as easy or difficult.

Ultrasonography is a valuable promising tool for preoperative airway evaluation through identifying important sonoanatomy of the upper airway such as epiglottis, thyroid cartilage, and vocal cords.

02

Conditions studied

  • Ultrasound
  • Difficult Laryngoscopy
  • Prediction
03

In context

Lead sponsor

Tanta University is the lead sponsor of 963 studies on the registry; 304 are open to participants now.

Of its 16 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

This retrospective observational study will be carried out on 85 patients at Tanta University Hospital in the anesthesia department over a period of one year from May 2022 to May 2023, which may be extended after approval from the institutional ethical committee of the faculty of medicine at Tanta University.

Laryngeal view grading according to the modified Cormack and Lehane grading scale where grades 1 and 2a are considered easy laryngoscopy and grades 2b, 3, and 4 are considered difficult laryngoscopy.

Inclusion criteria

  • Aged 18 - 65 years.
  • Both sexes.
  • Patients who aren't suspected to have a difficult airway after preoperative airway assessment by conventional clinical tests such as modified Mallampati classification (MMC), thyromental distance (TMD), inter-incisor distance (IID), cervical mobility (CM), And neck circumference (NC).
  • American society of anesthesia (ASA) I, II, and III physical status.
  • Scheduled for elective surgery under general anaethesia.

Exclusion criteria

Exclusion Criteria:

  • Patients with maxillofacial injury and airway trauma.
  • Patients with a history of previous difficult intubation.
  • Patients with anatomical abnormalities.
  • Neck scarring, swelling, or burn.
  • Pregnancy.
  • Obesity.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
85 participants (actual)
Patient registry
No

Groups and cohorts

  • Easy laryngoscopy

    Laryngeal view grading according to the modified Cormack and Lehane grading scale where grades 1 and 2a are considered easy laryngoscopy and grades 2b, 3, and 4 are considered difficult laryngoscopy.

    Procedure: Ultrasound

  • Difficult laryngoscopy

    Laryngeal view grading according to the modified Cormack and Lehane grading scale where grades 1 and 2a are considered easy laryngoscopy and grades 2b, 3, and 4 are considered difficult laryngoscopy.

    Procedure: Ultrasound

Interventions

  • ProcedureUltrasound

    Ultrasonographic parameters: in the parasagittal plane (1cm from midline) with the patient lying supine, without a pillow, head, and neck in the neutral position, looking straight ahead with mouth closed and the tongue on the floor of the mouth without any movement.

06

What researchers measure

Primary outcomes

  1. Correlation between the ultrasonographic parameters and the modified Cormack and Lehane grading scale

    Correlation between the ultrasonographic parameters (distance from skin to epiglottis ( DSE) and distance from skin to vocal cords (DSVC)) and the modified Cormack and Lehane grading scale of laryngoscopy as easy or difficult

    Time frame: 10 minutes during intubation.

Secondary outcomes

  1. Sensitivity of ultrasonographic distance from skin to epiglottis to predict difficult laryngoscopy.

    Measurement of Sensitivity of ultrasonographic distance from skin to epiglottis to predict difficult laryngoscopy. Laryngeal view grading according to the modified Cormack and Lehane grading scale where grades 1 and 2a are considered easy laryngoscopy and grades 2b, 3, and 4 are considered difficult laryngoscopy.

    Time frame: 10 minutes during intubation.

  2. Sensitivity of ultrasonographic distance from skin to vocal cords to easy laryngoscopy.

    Measurement of Sensitivity of ultrasonographic distance from skin to epiglottis to predict easy laryngoscopy. Laryngeal view grading according to the modified Cormack and Lehane grading scale where grades 1 and 2a are considered easy laryngoscopy and grades 2b, 3, and 4 are considered difficult laryngoscopy.

    Time frame: 10 minutes during intubation.

  3. Specificity of ultrasonographic distance from skin to epiglottis to predict difficult laryngoscopy.

    Measurement of Specificity of ultrasonographic distance from skin to epiglottis to predict difficult laryngoscopy. Laryngeal view grading according to the modified Cormack and Lehane grading scale where grades 1 and 2a are considered easy laryngoscopy and grades 2b, 3, and 4 are considered difficult laryngoscopy.

    Time frame: 10 minutes during intubation.

  4. Specificity of ultrasonographic distance from skin to vocal cords to easy laryngoscopy.

    Measurement of Specificity of ultrasonographic distance from skin to epiglottis to predict easy laryngoscopy. Laryngeal view grading according to the modified Cormack and Lehane grading scale where grades 1 and 2a are considered easy laryngoscopy and grades 2b, 3, and 4 are considered difficult laryngoscopy.

    Time frame: 10 minutes during intubation.

07

Study locations

1 site
  • Tanta University
    Tanta, El-Gharbia 31527, Egypt
08

References and documents

Individual participant data

Plan to share: Yes — The data will be available upon a reasonable request from the corresponding author after the end of the study for one year.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06052189
Lead sponsor
Tanta University
Responsible party
Ahmed Salah Eldein Shalaby Abotaleb (Resident of Anesthesiology, Surgical ICU, and Pain therapy, Tanta University) — Principal investigator
First posted
Sep 25, 2023
Start date
May 1, 2022
Primary completion
May 1, 2023
Completion
May 1, 2023
Last update
Sep 25, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion